Testosterone: a vascular hormone in health and disease
Open accessThe DOI matches its Crossref record; 221 of the 221 references it cites were found in a registry or an index.
Abstract
Coronary heart disease is a leading cause of premature death in men. Epidemiological studies have shown a high prevalence of low serum testosterone levels in men with cardiovascular disease (CVD). Furthermore, a low testosterone level is associated in some but not in all observational studies with an increase in cardiovascular events and mortality. Testosterone has beneficial effects on several cardiovascular risk factors, which include cholesterol, endothelial dysfunction and inflammation: key mediators of atherosclerosis. A bidirectional relationship between low endogenous testosterone levels and concurrent illness complicates attempts to validate causality in this association and potential mechanistic actions are complex. Testosterone is a vasoactive hormone that predominantly has vasodilatory actions on several vascular beds, although some studies have reported conflicting effects. In clinical studies, acute and chronic testosterone administration increases coronary artery diameter and flow, improves cardiac ischaemia and symptoms in men with chronic stable angina and reduces peripheral vascular resistance in chronic heart failure. Although the mechanism of the action of testosterone on vascular tone in vivo is not understood, laboratory research has found that testosterone is an L-calcium channel blocker and induces potassium channel activation in vascular smooth muscle cells. Animal studies have consistently demonstrated that testosterone is atheroprotective, whereas testosterone deficiency promotes the early stages of atherogenesis. The translational effects of testosterone between in vitro animal and human studies, some of which have conflicting effects, will be discussed in this review. We review the evidence for a role of testosterone in vascular health, its therapeutic potential and safety in hypogonadal men with CVD, and some of the possible underlying mechanisms.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
(1909) · Journal of the American Medical Association · doi:10.1001/jama.1909.02550020033007 · Cited by 7,866
Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis
Celermajer, D. S., Sorensen, K. E., Gooch, V. M., Spiegelhalter, D. J., Miller, O. I., Sullivan, I. D., Lloyd, J. K., & Deanfield, J. E. (1992) · The Lancet · doi:10.1016/0140-6736(92)93147-f · Cited by 4,742 · cited 4×
“A frequently used method for assessing vascular reactivity is the monitoring of changes in brachial artery diameter by a non-invasive ultrasound assessment as it is considered an accurate and reproducible measurement of endothelium-dependent response to shear stress (Celermajer et al. 1992, Takase et al. 1998). This m…”
MethodInfluentialHemodynamic Patterns of Age-Related Changes in Blood Pressure: The Framingham Heart Study
Franklin, S. S., Gustin, W., Wong, N. D., Larson, M. G., Weber, M. A., Kannel, W. B., & Levy, D. (1997) · Circulation · doi:10.1161/01.cir.96.1.308 · Cited by 2,321 · cited 1×
“The ageing blood vessel is less able to protect itself from injury induced by diseases such as dyslipidaemia, T2DM and obesity, with a loss of compliance in the aorta and the principal arterial conduits (Franklin et al. 1997).”
BackgroundClose Relation of Endothelial Function in the Human Coronary and Peripheral Circulations
Anderson, T. J., Uehata, A., Gerhard, M. D., Meredith, I. T., Knab, S., Delagrange, D., Lieberman, E. H., Ganz, P., Creager, M. A., Yeung, A. C., et al. (1995) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(95)00327-4 · Cited by 2,033 · cited 1×
“This measure is a marker for increased cardiovascular risk (Kuvin et al. 2001) and correlates with endothelium-dependent coronary and peripheral artery responses (Anderson et al. 1995, Sorensen et al. 1995).”
BackgroundDavis, H. S. (1966) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1966.03100200106038 · Cited by 1,719
Adverse Events Associated with Testosterone Administration
Basaria, S., Coviello, A. D., Travison, T. G., Storer, T. W., Farwell, W. R., Jette, A. M., Eder, R., Tennstedt, S., Ulloor, J., Zhang, A., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1000485 · Cited by 1,494
Aortic pulse wave velocity as a marker of cardiovascular risk in hypertensive patients
Blacher, J., Asmar, R., Djane, S., London, G. M., & Safar, M. E. (1999) · Hypertension · doi:10.1161/01.hyp.33.5.1111 · Cited by 1,493 · cited 1×
“In turn, this loss of compliance is a powerful determinant of cardiovascular risk and the development of atherosclerosis (Blacher et al. 1999).”
BackgroundDiabetes and cardiovascular disease during androgen deprivation therapy for prostate cancer
Keating, N. L., O'Malley, A. J., & Smith, M. R. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2006.06.2497 · Cited by 1,455 · cited 1×
“ADT for the treatment of prostate cancer increases the risk of CHD, diabetes and cardiovascular death (Keating et al. 2006, Levine et al. 2010, Jones 2011).”
BackgroundInteraction of oestrogen receptor with the regulatory subunit of phosphatidylinositol-3-OH kinase
Simoncini, T., Hafezi-Moghadam, A., Brazil, D. P., Ley, K., Chin, W. W., & Liao, J. K. (2000) · Nature · doi:10.1038/35035131 · Cited by 1,436
4 Histology and Histopathology
(2015) · Burghardt’s Colposcopy and Cervical Pathology · doi:10.1055/b-0035-108581 · Cited by 1,043
Chen, Z., Yuhanna, I. S., Galcheva-Gargova, Z., Karas, R. H., Mendelsohn, M. E., & Shaul, P. W. (1999) · Journal of Clinical Investigation · doi:10.1172/jci5347 · Cited by 923
(1973) · New England Journal of Medicine · doi:10.1056/nejm197307122890231 · Cited by 895
NILSSEN, O., FØRDE, O. H., & BRENN, T. (1990) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a115661 · Cited by 815
Low Serum Testosterone and Mortality in Older Men
Laughlin, G. A., Barrett-Connor, E., & Bergstrom, J. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-1792 · Cited by 798
Khaw, K.-T., Dowsett, M., Folkerd, E., Bingham, S., Wareham, N., Luben, R., Welch, A., & Day, N. (2007) · Circulation · doi:10.1161/circulationaha.107.719005 · Cited by 743
Malkin, C. J., Pugh, P. J., Jones, R. D., Kapoor, D., Channer, K. S., & Jones, T. H. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-031069 · Cited by 731
Self-citationAdverse Effects of Testosterone Therapy in Adult Men: A Systematic Review and Meta-Analysis
Fernández-Balsells, M. M., Murad, M. H., Lane, M., Lampropulos, J. F., Albuquerque, F., Mullan, R. J., Agrwal, N., Elamin, M. B., Gallegos-Orozco, J. F., Wang, A. T., et al. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-2575 · Cited by 713
Repression of the Interleukin-6 Promoter by Estrogen Receptor Is Mediated by NF-κB and C/EBPβ
Stein, B., & Yang, M. X. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.9.4971 · Cited by 704
Sorensen, K. E., Celermajer, D. S., Spiegelhalter, D. J., Georgakopoulos, D., Robinson, J., Thomas, O., & Deanfield, J. E. (1995) · Heart · doi:10.1136/hrt.74.3.247 · Cited by 694
Endogenous Testosterone and Mortality in Men: A Systematic Review and Meta-Analysis
Araujo, A. B., Dixon, J. M., Suarez, E. A., Murad, M. H., Guey, L. T., & Wittert, G. A. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-1137 · Cited by 671
Wang, C., Cunningham, G., Dobs, A., Iranmanesh, A., Matsumoto, A. M., Snyder, P. J., Weber, T., Berman, N., Hull, L., & Swerdloff, R. S. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-032006 · Cited by 656 · cited 1×
“Clinical studies, however, have revealed either small reductions of 2–3 mm in diastolic pressure or no significant effects when testosterone is replaced within normal physiological limits in humans (Wang et al. 2004, Jones & Saad 2009).”
BackgroundClarke, M. C. H., Figg, N., Maguire, J. J., Davenport, A. P., Goddard, M., Littlewood, T. D., & Bennett, M. R. (2006) · Nature Medicine · doi:10.1038/nm1459 · Cited by 646
Srinivas-Shankar, U., Roberts, S. A., Connolly, M. J., O'Connell, M. D. L., Adams, J. E., Oldham, J. A., & Wu, F. C. W. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-1251 · Cited by 629
Recent developments in nitric oxide donor drugs
Miller, M. R., & Megson, I. L. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707224 · Cited by 628
Androgens and Coronary Artery Disease
Wu, F. C. W., & von Eckardstein, A. (2003) · Endocrine Reviews · doi:10.1210/er.2001-0025 · Cited by 592
A history of prostate cancer treatment.
Denmeade, S. R., & Isaacs, J. T. (2002) · Nature reviews. Cancer · doi:10.1038/nrc801 · Cited by 591
English, K. M., Steeds, R. P., Jones, T. H., Diver, M. J., & Channer, K. S. (2000) · Circulation · doi:10.1161/01.cir.102.16.1906 · Cited by 582
Self-citationTestosterone: a metabolic hormone in health and disease
Kelly, D. M., & Jones, T. H. (2013) · Journal of Endocrinology · doi:10.1530/joe-12-0455 · Cited by 577
Self-citationThe Roles of Androgen Receptors and Androgen-Binding Proteins in Nongenomic Androgen Actions
Heinlein, C. A., & Chang, C. (2002) · Molecular Endocrinology · doi:10.1210/me.2002-0070 · Cited by 568 · cited 1×
“…of http://joe.endocrinology-journals.org 2013 Society for Endocrinology DOI: 10.1530/JOE-12-0582 Printed in Great Britain G-protein-coupled, agonist-sequestrable receptors that initiate rapid intracellular signalling cascades and transcription-independent signalling (Heinlein & Chang 2002).”
BackgroundInfluentialHak, A. E. (2002) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.87.8.3632 · Cited by 480
Smith, J. C., Bennett, S., Evans, L. M., Kynaston, H. G., Parmar, M., Mason, M. D., Cockcroft, J. R., Scanlon, M. F., & Davies, J. S. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.9.7851 · Cited by 458
Takase, B., Uehata, A., Akima, T., Nagai, T., Nishioka, T., Hamabe, A., Satomura, K., Ohsuzu, F., & Kurita, A. (1998) · The American Journal of Cardiology · doi:10.1016/s0002-9149(98)00702-4 · Cited by 452
Effects of Testosterone on Coronary Vasomotor Regulation in Men With Coronary Heart Disease
Webb, C. M., McNeill, J. G., Hayward, C. S., de Zeigler, D., & Collins, P. (1999) · Circulation · doi:10.1161/01.cir.100.16.1690 · Cited by 451 · cited 4×
“…2004b). ac ischaemia Outcome References n Increased coronary artery dilatation following Ach-induced contraction and increased coronary blood flow Webb et al. (1999a) Increased time to 1 mm ST-segment depression Webb et al. (1999b) Increased time to 1 mm ST-segment depression post-exercise;…”
BackgroundInfluentialCaminiti, G., Volterrani, M., Iellamo, F., Marazzi, G., Massaro, R., Miceli, M., Mammi, C., Piepoli, M., Fini, M., & Rosano, G. M. C. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.04.078 · Cited by 444
Hypogonadism as a risk factor for cardiovascular mortality in men: a meta-analytic study
Corona, G., Rastrelli, G., Monami, M., Guay, A., Buvat, J., Sforza, A., Forti, G., Mannucci, E., & Maggi, M. (2011) · European Journal of Endocrinology · doi:10.1530/eje-11-0447 · Cited by 435 · cited 1×
“There are, however, a number of systematic meta-analyses of clinical trials of TRT that have not demonstrated an increased risk of adverse cardiovascular events or mortality (Haddad et al. 2007, Fernández-Balsells et al. 2010, Corona et al. 2011, Carson & Rosano 2011).”
BackgroundNguyen, P. L., Je, Y., Schutz, F. A. B., Hoffman, K. E., Hu, J. C., Parekh, A., Beckman, J. A., & Choueiri, T. K. (2011) · JAMA · doi:10.1001/jama.2011.1745 · Cited by 432
Functional analysis of the human vascular cell adhesion molecule 1 promoter.
Neish, A. S., Williams, A. J., Palmer, H. J., Whitley, M. Z., & Collins, T. (1992) · The Journal of experimental medicine · doi:10.1084/jem.176.6.1583 · Cited by 424
Testosterone Relaxes Rabbit Coronary Arteries and Aorta
Yue, P., Chatterjee, K., Beale, C., Poole-Wilson, P. A., & Collins, P. (1995) · Circulation · doi:10.1161/01.cir.91.4.1154 · Cited by 414
Malkin, C. J., Pugh, P. J., West, J. N., van Beek, E. J. R., Jones, T. H., & Channer, K. S. (2006) · European Heart Journal · doi:10.1093/eurheartj/ehi443 · Cited by 413
Self-citationSHABSIGH, R., KAUFMAN, J. M., STEIDLE, C., & PADMA-NATHAN, H. (2004) · Journal of Urology · doi:10.1097/01.ju.0000132389.97804.d7 · Cited by 406
NF-kappa B and I kappa B alpha: an inducible regulatory system in endothelial activation.
Read, M. A., Whitley, M. Z., Williams, A. J., & Collins, T. (1994) · The Journal of experimental medicine · doi:10.1084/jem.179.2.503 · Cited by 405
McKay, L. I., & Cidlowski, J. A. (1998) · Molecular Endocrinology · doi:10.1210/mend.12.1.0044 · Cited by 405
Transcription factor cross-talk: the estrogen receptor and NF-κB
Kalaitzidis, D., & Gilmore, T. D. (2005) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2005.01.004 · Cited by 388
Levine, G. N., D'Amico, A. V., Berger, P., Clark, P. E., Eckel, R. H., Keating, N. L., Milani, R. V., Sagalowsky, A. I., Smith, M. R., & Zakai, N. (2010) · Circulation · doi:10.1161/circulationaha.109.192695 · Cited by 383
Acute Anti-Ischemic Effect of Testosterone in Men With Coronary Artery Disease
Rosano, G. M. C., Leonardo, F., Pagnotta, P., Pelliccia, F., Panina, G., Cerquetani, E., della Monica, P. L., Bonfigli, B., Volpe, M., & Chierchia, S. L. (1999) · Circulation · doi:10.1161/01.cir.99.13.1666 · Cited by 367
Endogenous sex hormones and cardiovascular disease in men. A prospective population-based study.
Barrett-Connor, E., & Khaw, K. T. (1988) · Circulation · doi:10.1161/01.cir.78.3.539 · Cited by 366
English, K. (2000) · European Heart Journal · doi:10.1053/euhj.1999.1873 · Cited by 350
The cardiac toxicity of anabolic steroids
Sullivan, M. L., Martinez, C. M., Gennis, P., & Gallagher, E. J. (1998) · Progress in Cardiovascular Diseases · doi:10.1016/s0033-0620(98)80019-4 · Cited by 342
Effects of 17beta-estradiol on cytokine-induced endothelial cell adhesion molecule expression.
Caulin-Glaser, T., Watson, C. A., Pardi, R., & Bender, J. R. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118774 · Cited by 342
Kalinchenko, S. Y., Tishova, Y. A., Mskhalaya, G. J., Gooren, L. J. G., Giltay, E. J., & Saad, F. (2010) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2010.03845.x · Cited by 341
Reckelhoff, J. F., Zhang, H., & Granger, J. P. (1998) · Hypertension · doi:10.1161/01.hyp.31.1.435 · Cited by 333
Haddad, R. M., Kennedy, C. C., Caples, S. M., Tracz, M. J., Boloña, E. R., Sideras, K., Uraga, M. V., Erwin, P. J., & Montori, V. M. (2007) · Mayo Clinic Proceedings · doi:10.4065/82.1.29 · Cited by 331
Endogenous Sex Hormones and Progression of Carotid Atherosclerosis in Elderly Men
Muller, M., van den Beld, A. W., Bots, M. L., Grobbee, D. E., Lamberts, S. W. J., & van der Schouw, Y. T. (2004) · Circulation · doi:10.1161/01.cir.0000125854.51637.06 · Cited by 321
Testosterone Induces Dilation of Canine Coronary Conductance and Resistance Arteries In Vivo
Chou, T. M., Sudhir, K., Hutchison, S. J., Ko, E., Amidon, T. M., Collins, P., & Chatterjee, K. (1996) · Circulation · doi:10.1161/01.cir.94.10.2614 · Cited by 312
DOCKERY, F., BULPITT, C. J., AGARWAL, S., DONALDSON, M., & RAJKUMAR, C. (2003) · Clinical Science · doi:10.1042/cs1040195 · Cited by 294
High Serum Testosterone Is Associated With Reduced Risk of Cardiovascular Events in Elderly Men
Ohlsson, C., Barrett-Connor, E., Bhasin, S., Orwoll, E., Labrie, F., Karlsson, M. K., Ljunggren, Ö., Vandenput, L., Mellström, D., & Tivesten, Å. (2011) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2011.07.019 · Cited by 292
Androgens Regulate Phosphodiesterase Type 5 Expression and Functional Activity in Corpora Cavernosa
Morelli, A., Filippi, S., Mancina, R., Luconi, M., Vignozzi, L., Marini, M., Orlando, C., Vannelli, G. B., Aversa, A., Natali, A., et al. (2004) · Endocrinology · doi:10.1210/en.2003-1699 · Cited by 286
Lugg, J. A. (1995) · Endocrinology · doi:10.1210/en.136.4.1495 · Cited by 279
Bartlett, D. B., Firth, C. M., Phillips, A. C., Moss, P., Baylis, D., Syddall, H., Sayer, A. A., Cooper, C., & Lord, J. M. (2012) · Aging Cell · doi:10.1111/j.1474-9726.2012.00849.x · Cited by 278
Effects of Castration and Androgen Replacement on Erectile Function in a Rabbit Model1
Traish, A. M., Park, K., Dhir, V., Kim, N. N., Moreland, R. B., & Goldstein, I. (1999) · Endocrinology · doi:10.1210/endo.140.4.6655 · Cited by 276
Contrasting Effects of Testosterone and Stanozolol on Serum Lipoprotein Levels
Thompson, P. D. (1989) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1989.03420080085036 · Cited by 274
Svartberg, J., von Muhlen, D., Schirmer, H., Barrett-Connor, E., Sundfjord, J., & Jorde, R. (2004) · European Journal of Endocrinology · doi:10.1530/eje.0.1500065 · Cited by 270
Kalinchenko, S. Y., Tishova, Y. A., Mskhalaya, G. J., Gooren, L. J. G., Giltay, E. J., & Saad, F. (2011) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2011.04105.x · Cited by 267
Endogenous Hormones and Carotid Atherosclerosis in Elderly Men
van den Beld, A. W. (2003) · American Journal of Epidemiology · doi:10.1093/aje/kwf160 · Cited by 263
Natural Androgens Inhibit Male Atherosclerosis: A Study in Castrated, Cholesterol-Fed Rabbits
Alexandersen, P., Haarbo, J., Byrjalsen, I., Lawaetz, H., & Christiansen, C. (1999) · Circulation Research · doi:10.1161/01.res.84.7.813 · Cited by 254
Malkin, C. J., Pugh, P. J., Morris, P. D., Kerry, K. E., Jones, R. D., Jones, T. H., & Channer, K. S. (2004) · Heart · doi:10.1136/hrt.2003.021121 · Cited by 250 · cited 21×
“…et al. (2001) and Jones et al. (2002) Rowell et al. (2009) Jones et al. (2004c) Tep-areenan et al. (2002) and Toot et al. (2012) Seyrek et al. (2007) Malkin et al. (2004a) Lu et al. (2012) Perusquı́a et al. (2007) and Cairrão et al. (2008) Navarro-Dorado et al. (2008) Yildiz et al. (2005)…”
BackgroundInfluentialSelf-citationTestosterone inhibits early atherogenesis by conversion to estradiol: Critical role of aromatase
Nathan, L., Shi, W., Dinh, H., Mukherjee, T. K., Wang, X., Lusis, A. J., & Chaudhuri, G. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.051003698 · Cited by 248
Kuvin, J. T., Patel, A. R., Sliney, K. A., Pandian, N. G., Rand, W. M., Udelson, J. E., & Karas, R. H. (2001) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(01)01657-6 · Cited by 248
McCrohon, J. A., Jessup, W., Handelsman, D. J., & Celermajer, D. S. (1999) · Circulation · doi:10.1161/01.cir.99.17.2317 · Cited by 242
Ly, L. P. (2001) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.86.9.4078 · Cited by 241
Effect of acute testosterone on myocardial ischemia in men with coronary artery disease
Webb, C. M., Adamson, D. L., de Zeigler, D., & Collins, P. (1999) · The American Journal of Cardiology · doi:10.1016/s0002-9149(98)00880-7 · Cited by 241
Low serum testosterone and increased mortality in men with coronary heart disease
Malkin, C. J., Pugh, P. J., Morris, P. D., Asif, S., Jones, T. H., & Channer, K. S. (2010) · Heart · doi:10.1136/hrt.2010.195412 · Cited by 236 · cited 5×
“The physiological and supraphysiological concentrations of testosterone reduced the expression and secretion of TNFa and IL1b in monocyte-derived macrophages obtained from a CHD age-relevant population, although no effects were observed on IL6 and CRP expression (Corcoran et al. 2010).”
BackgroundInfluentialSelf-citationCid, M. C., Kleinman, H. K., Grant, D. S., Schnaper, H. W., Fauci, A. S., & Hoffman, G. S. (1994) · Journal of Clinical Investigation · doi:10.1172/jci116941 · Cited by 235
Kapoor, D., Clarke, S., Stanworth, R., Channer, K. S., & Jones, T. H. (2007) · European Journal of Endocrinology · doi:10.1530/eje-06-0737 · Cited by 234
Self-citationSimon, D. (1997) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.82.2.682 · Cited by 220
Hou, J., Baichwal, V, & Cao, Z. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.24.11641 · Cited by 217
Testosterone inhibits immunoglobulin production by human peripheral blood mononuclear cells
Kanda, N., Tsuchida, T., & Tamaki, K. (2003) · Clinical and Experimental Immunology · doi:10.1046/j.1365-2249.1996.d01-842.x · Cited by 216
Deenadayalu, V. P., White, R. E., Stallone, J. N., Gao, X., & Garcia, A. J. (2001) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.2001.281.4.h1720 · Cited by 212
Aversa, A., Isidori, A. M., De Martino, M. U., Caprio, M., Fabbrini, E., Rocchietti‐March, M., Frajese, G., & Fabbri, A. (2000) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2000.01118.x · Cited by 205
Insulin Resistance and Diminished Glucose Tolerance in Powerlifters Ingesting Anabolic Steroids*
COHEN, J. C., & HICKMAN, R. (1987) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-64-5-960 · Cited by 203
Maggio, M., Basaria, S., Ble, A., Lauretani, F., Bandinelli, S., Ceda, G. P., Valenti, G., Ling, S. M., & Ferrucci, L. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-1097 · Cited by 200 · cited 1×
“…cytokines (including interleukin 1b (IL1b), IL6, tumour necrosis factor a (TNFa), and highly sensitive CRP) and serum testosterone levels are inversely associated in patients with CAD, T2DM and/or hypogonadism (Yang et al. 2005, Maggio et al. 2006, Kapoor et al. 2007, Nettleship et al. 2007b).”
BackgroundSex hormone-binding globulin mediates steroid hormone signal transduction at the plasma membrane
Rosner, W., Hryb, D. J., Khan, M. S., Nakhla, A. M., & Romas, N. A. (1999) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/s0960-0760(99)00070-9 · Cited by 195
Testosterone deficiency: a risk factor for cardiovascular disease?
Jones, T. H. (2010) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2010.03.002 · Cited by 194
Self-citationKhosla, S., Atkinson, E. J., Dunstan, C. R., & O’Fallon, W. M. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.87.4.8397 · Cited by 191 · cited 1×
“Khosla et al. (2002) reported that TNFa, IL6 and IL6 soluble receptor were elevated in elderly men where hypogonadism was induced by GNRH antagonists.”
BackgroundBlood pressure and endogenous testosterone in men: an inverse relationship.
Khaw, K., & Barrett-Connor, E. L. (1988) · PubMed · Cited by 191
Kaszubska, W., Hooft van Huijsduijnen, R., Ghersa, P., DeRaemy-Schenk, A. M., Chen, B. P., Hai, T., DeLamarter, J. F., & Whelan, J. (1993) · Molecular and Cellular Biology · doi:10.1128/mcb.13.11.7180 · Cited by 184
Localized Expression of Aromatase in Human Vascular Tissues
Harada, N., Sasano, H., Murakami, H., Ohkuma, T., Nagura, H., & Takagi, Y. (1999) · Circulation Research · doi:10.1161/01.res.84.11.1285 · Cited by 184
Acute haemodynamic effects of testosterone in men with chronic heart failure
Pugh, P. (2003) · European Heart Journal · doi:10.1016/s0195-668x(03)00083-6 · Cited by 184
Simoncini, T., Maffei, S., Basta, G., Barsacchi, G., Genazzani, A. R., Liao, J. K., & De Caterina, R. (2000) · Circulation Research · doi:10.1161/01.res.87.1.19 · Cited by 182
Serum adiponectin levels in hypogonadal males: influence of testosterone replacement therapy
Lanfranco, F., Zitzmann, M., Simoni, M., & Nieschlag, E. (2004) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2004.02007.x · Cited by 180
Kenny, A. M., Bellantonio, S., Gruman, C. A., Acosta, R. D., & Prestwood, K. M. (2002) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/57.5.m321 · Cited by 177
Corcoran, M. P., Meydani, M., Lichtenstein, A. H., Schaefer, E. J., Dillard, A. C., & Lamon‐Fava, S. (2010) · Journal of Endocrinology · doi:10.1677/joe-10-0057 · Cited by 174
Kalinchenko, S. Y., Kozlov, G. I., Gontcharov, N. P., & Katsiya, G. V. (2003) · The Aging Male · doi:10.1080/tam.6.2.94.99 · Cited by 173
Matrix metalloproteinases: influence on smooth muscle cells and atherosclerotic plaque stability
Johnson, J. L. (2007) · Expert Review of Cardiovascular Therapy · doi:10.1586/14779072.5.2.265 · Cited by 172
Testosterone is a potent inhibitor of L-type Ca2+ channels
Scragg, J. L., Jones, R. D., Channer, K. S., Jones, T. H., & Peers, C. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.04.054 · Cited by 170
Self-citationVikan, T., Schirmer, H., Njølstad, I., & Svartberg, J. (2009) · European Journal of Endocrinology · doi:10.1530/eje-09-0284 · Cited by 167
Increased Carotid Atherosclerosis in Andropausal Middle-Aged Men
Mäkinen, J., Järvisalo, M. J., Pöllänen, P., Perheentupa, A., Irjala, K., Koskenvuo, M., Mäkinen, J., Huhtaniemi, I., & Raitakari, O. T. (2005) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.01.052 · Cited by 166
Androgen Deprivation Is Associated With Enhanced Endothelium-Dependent Dilatation in Adult Men
Herman, S. M., Robinson, J. T. C., McCredie, R. J., Adams, M. R., Boyer, M. J., & Celermajer, D. S. (1997) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.17.10.2004 · Cited by 166
The effects of testosterone on risk factors for, and the mediators of, the atherosclerotic process
Jones, T. H., & Saad, F. (2009) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2009.04.016 · Cited by 165
Self-citationLow testosterone levels are associated with carotid atherosclerosis in men
SVARTBERG, J., VON MÜHLEN, D., MATHIESEN, E., JOAKIMSEN, O., BØNAA, K. H., & STENSLAND‐BUGGE, E. (2006) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2006.01637.x · Cited by 164
Norata, G. D., Tibolla, G., Seccomandi, P. M., Poletti, A., & Catapano, A. L. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-1664 · Cited by 163
Testosterone Administration Suppresses Adiponectin Levels in Men
Page, S. T., Herbst, K. L., Amory, J. K., Coviello, A. D., Anawalt, B. D., Matsumoto, A. M., & Bremner, W. J. (2005) · Journal of Andrology · doi:10.1002/j.1939-4640.2005.tb02876.x · Cited by 162
Crews, J. K., & Khalil, R. A. (1999) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.19.4.1034 · Cited by 162
Death, A. K., McGrath, K. C. Y., Sader, M. A., Nakhla, S., Jessup, W., Handelsman, D. J., & Celermajer, D. S. (2004) · Endocrinology · doi:10.1210/en.2003-0789 · Cited by 159
Mukherjee, T. K., Dinh, H., Chaudhuri, G., & Nathan, L. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.052703199 · Cited by 158
Effect of testosterone cypionate on postexercise ST segment depression.
Jaffe, M. D. (1977) · Heart · doi:10.1136/hrt.39.11.1217 · Cited by 155
Testosterone enhances flow-mediated brachial artery reactivity in men with coronary artery disease
Ong, P. J. L., Patrizi, G., Chong, W. C. F., Webb, C. M., Hayward, C., & Collins, P. (2000) · The American Journal of Cardiology · doi:10.1016/s0002-9149(99)00630-x · Cited by 154
Jones, R. D., Pugh, P. J., Jones, T. H., & Channer, K. S. (2003) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0705141 · Cited by 153 · cited 8×
“…key mechanism underlying the potential vasodilatory actions of testosterone has been proposed by several studies to involve an effect on smooth muscle cell ion channel function, influencing either potassium (KC) channel opening and/or calcium (Ca2C) channel inactivation (Jones et al. 2003b) (Fig.”
BackgroundInfluentialSelf-citationLong-term benefits of testosterone replacement therapy on angina threshold and atheroma in men
Mathur, A., Malkin, C., Saeed, B., Muthusamy, R., Jones, T. H., & Channer, K. (2009) · European Journal of Endocrinology · doi:10.1530/eje-09-0092 · Cited by 151
Self-citationWilliams, M. R. I. (2002) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.87.1.176 · Cited by 148
Supakar, P. C., Jung, M. H., Song, C. S., Chatterjee, B., & Roy, A. K. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.2.837 · Cited by 147
Murphy, J. G., & Khalil, R. A. (1999) · PubMed · Cited by 142
Antiinflammatory effect of androgen receptor activation in human benign prostatic hyperplasia cells
Vignozzi, L., Cellai, I., Santi, R., Lombardelli, L., Morelli, A., Comeglio, P., Filippi, S., Logiodice, F., Carini, M., Nesi, G., et al. (2012) · Journal of Endocrinology · doi:10.1530/joe-12-0142 · Cited by 139
Testosterone acts as a coronary vasodilator by a calcium antagonistic action
English, K. M., Jones, R. D., Jones, T. H., Morice, A. H., & Channer, K. S. (2002) · Journal of Endocrinological Investigation · doi:10.1007/bf03344037 · Cited by 139
Self-citationYu, J., Akishita, M., Eto, M., Ogawa, S., Son, B., Kato, S., Ouchi, Y., & Okabe, T. (2010) · Endocrinology · doi:10.1210/en.2009-1048 · Cited by 137
Bruck, B., Brehme, U., Gugel, N., Hanke, S., Finking, G., Lutz, C., Benda, N., Schmahl, F. W., Haasis, R., & Hanke, H. (1997) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.17.10.2192 · Cited by 137
Honda, H., Unemoto, T., & Kogo, H. (1999) · Hypertension · doi:10.1161/01.hyp.34.6.1232 · Cited by 136
Gender‐Specific Inhibition of Ca2+ Entry Mechanisms of Arterial Vasoconstriction by Sex Hormones
Crews, J. K., & Khalil, R. A. (1999) · Clinical and Experimental Pharmacology and Physiology · doi:10.1046/j.1440-1681.1999.03110.x · Cited by 135
Androgen and Pituitary Control of Penile Nitric Oxide Synthase and Erectile Function in the Rat1
Penson, D. F., Ng, C., Cai, L., Rajfer, J., & González-Cadavid, N. F. (1996) · Biology of Reproduction · doi:10.1095/biolreprod55.3.567 · Cited by 133
Tep‐areenan, P., Kendall, D. A., & Randall, M. D. (2002) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0704522 · Cited by 133
Xing, D., Feng, W., Miller, A. P., Weathington, N. M., Chen, Y.-F., Novak, L., Blalock, J. E., & Oparil, S. (2007) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.01107.2006 · Cited by 132
Zitzmann, M. (2001) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.86.10.4867 · Cited by 130
The influence of testosterone upon vascular reactivity
Jones, R., Jones, T. H., & Channer, K. S. (2004) · European Journal of Endocrinology · doi:10.1530/eje.0.1510029 · Cited by 127
Self-citationHougaku, H., Fleg, J. L., Najjar, S. S., Lakatta, E. G., Harman, S. M., Blackman, M. R., & Metter, E. J. (2006) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00059.2005 · Cited by 125
Sex steroids and endothelial function: translating basic science to clinical practice
MILLER, V., & Mulvagh, S. L. (2007) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2007.04.004 · Cited by 124
English, K. M., Jones, R. D., Jones, T. H., Morice, A. H., & Channer, K. S. (2001) · Hormone and Metabolic Research · doi:10.1055/s-2001-18689 · Cited by 124
Self-citationPulmonary Vasodilatory Action of Testosterone: Evidence of a Calcium Antagonistic Action
Jones, R. D., English, K. M., Pugh, P. J., Morice, A. H., Jones, T. H., & Channer, K. S. (2002) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-200206000-00006 · Cited by 122
Self-citationOestrogen relaxes human epicardial coronary arteries through non-endothelium-dependent mechanisms
Chester, A. H., Jiang, C., Borland, J. A., Yacoub, M. H., & Collins, P. (1995) · Coronary Artery Disease · doi:10.1097/00019501-199505000-00009 · Cited by 121
Corona, G., Mannucci, E., Ricca, V., Lotti, F., Boddi, V., Bandini, E., Balercia, G., Forti, G., & Maggi, M. (2009) · International Journal of Andrology · doi:10.1111/j.1365-2605.2009.00952.x · Cited by 121
Nettleship, J. E., Jones, T. H., Channer, K. S., & Jones, R. D. (2007) · Circulation · doi:10.1161/circulationaha.107.708768 · Cited by 120
Self-citationDing, A. Q., & Stallone, J. N. (2001) · Journal of Applied Physiology · doi:10.1152/jappl.2001.91.6.2742 · Cited by 119
Testosterone supplementation in aging men and women: possible impact on cardiovascular-renal disease
Reckelhoff, J. F., Yanes, L. L., Iliescu, R., Fortepiani, L. A., & Granger, J. P. (2005) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00034.2005 · Cited by 118
Blood pressure and endogenous testosterone in men: an inverse relationship
Khaw, K.-T., & Barrett-Connor, E. (1988) · Journal of Hypertension · doi:10.1097/00004872-198804000-00010 · Cited by 118
Sex hormones and hemostatic risk factors for coronary heart disease in men with hypertension
Phillips, G. B., Jing, T.-Y., Resnick, L. M., Barbagallo, M., Laragh, J. H., & Sealey, J. E. (1993) · Journal of Hypertension · doi:10.1097/00004872-199307000-00003 · Cited by 117 · cited 2×
“There is also an inverse relationship between the degree of coronary atherosclerosis and testosterone (Phillips et al. 1993, Nettleship et al. 2007b).”
BackgroundAndrogen Receptor-Dependent and Independent Atheroprotection by Testosterone in Male Mice
Fagman, J. B., Wilhelmson, A. S., Alexanderson, C., Gendt, K. D., Verhoeven, G., Krettek, A., Ohlsson, C., & Tivesten, Å. (2010) · Endocrinology · doi:10.1210/en.2010-0663 · Cited by 116
GREENSTEIN, A., MABJEESH, N. J., SOFER, M., KAVER, I., MATZKIN, H., & CHEN, J. (2005) · Journal of Urology · doi:10.1097/01.ju.0000149870.36577.05 · Cited by 116
Teoh, H., Quan, A., Leung, S. W. S., & Man, R. Y. K. (2000) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0703164 · Cited by 114
Fukui, M., Kitagawa, Y., Nakamura, N., Kadono, M., Mogami, S., Hirata, C., Ichio, N., Wada, K., Hasegawa, G., & Yoshikawa, T. (2003) · Diabetes Care · doi:10.2337/diacare.26.6.1869 · Cited by 114
Corrales, J. J., Almeida, M., Burgo, R., Mories, M. T., Miralles, J. M., & Orfao, A. (2006) · Journal of Endocrinology · doi:10.1677/joe.1.06779 · Cited by 110
Selective Inhibition of L-Type Ca2+ Channels in A7r5 Cells by Physiological Levels of Testosterone
Hall, J., Jones, R. D., Jones, T. H., Channer, K. S., & Peers, C. (2006) · Endocrinology · doi:10.1210/en.2005-1243 · Cited by 109
Self-citationJohannsson, G., Gibney, J., Wolthers, T., Leung, K.-C., & Ho, K. K. Y. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-0553 · Cited by 106
Kang, S.-M., Jang, Y., Kim, J. I.-Y., Chung, N., Cho, S.-Y., Chae, J. S., & Lee, J.-H. O. (2002) · The American Journal of Cardiology · doi:10.1016/s0002-9149(02)02202-6 · Cited by 105 · cited 1×
“Indeed, 12-week oral testosterone treatment, which produced plasma free testosterone levels within the physiological range, has been shown to result in a marked increase in both flow- and nitroglycerin-mediated brachial artery vasodilation in men with CAD (Kang et al. 2002).”
BackgroundSex steroid hormones are altered in essential hypertension
Hughes, G. S., Mathur, R. S., & Margolius, H. S. (1989) · Journal of Hypertension · doi:10.1097/00004872-198903000-00003 · Cited by 105
Aziz, K. E., & Wakefield, D. (1996) · Cellular Immunology · doi:10.1006/cimm.1996.0010 · Cited by 104
Sz, W., & Xz, W. (1993) · PubMed · Cited by 104
GUAY, A. T., PEREZ, J. B., JACOBSON, J., & NEWTON, R. A. (2001) · Journal of Andrology · doi:10.1002/j.1939-4640.2001.tb02582.x · Cited by 103
Hatakeyama, H., Nishizawa, M., Nakagawa, A., Nakano, S., Kigoshi, T., & Uchida, K. (2002) · FEBS Letters · doi:10.1016/s0014-5793(02)03440-3 · Cited by 103
Goglia, L., Tosi, V., Sanchez, A. M., Flamini, M. I., Fu, X., Zullino, S., Genazzani, A. R., & Simoncini, T. (2010) · Molecular Human Reproduction · doi:10.1093/molehr/gaq049 · Cited by 100
Role of endothelium in the vasodilating effect of progestins and androgens on the rat thoracic aorta
Perusquı́a, M., Hernández, R., Morales, M. A., Campos, M. G., & Villalón, C. M. (1996) · General Pharmacology The Vascular System · doi:10.1016/0306-3623(95)00091-7 · Cited by 99
Acute and Nongenomic Effects of Testosterone on Isolated and Perfused Rat Heart
Ceballos, G. M., Lauro, F., Rubio‐Gayosso, I., Gallo, G. M., García, A., Martinez, A., Yañez, R., Pérez, J., Morato, T., & Chamorro, G. (1999) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-199905000-00003 · Cited by 98
Effects of testosterone on Type 2 diabetes and components of the metabolic syndrome
JONES, T. H. (2010) · Journal of Diabetes · doi:10.1111/j.1753-0407.2010.00085.x · Cited by 92
Self-citationSchrör, K., Morinelli, T. A., Masuda, A., Matsuda, K., Mathur, R. S., & Halushka, P. V. (1994) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.1994.tb02428.x · Cited by 89
Effects of Testosterone on Antioxidant Systems in Male Secondary Hypogonadism
Mancini, A., Leone, E., Festa, R., Grande, G., Silvestrini, A., Marinis, L. D., Pontecorvi, A., Maira, G., Littarru, G. P., & Meucci, E. (2008) · Journal of Andrology · doi:10.2164/jandrol.107.004838 · Cited by 88
McKay, L. I. (1997) · Molecular Endocrinology · doi:10.1210/me.12.1.45 · Cited by 87
Vascular Reactivity in Hypogonadal Men Is Reduced by Androgen Substitution
Zitzmann, M., Brune, M., & Nieschlag, E. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-020504 · Cited by 86
Ota, H., Akishita, M., Akiyoshi, T., Kahyo, T., Setou, M., Ogawa, S., Iijima, K., Eto, M., & Ouchi, Y. (2012) · PLoS ONE · doi:10.1371/journal.pone.0029598 · Cited by 86
JONES, R. D., ENGLISH, K. M., JONES, T. H., & CHANNER, K. S. (2004) · Clinical Science · doi:10.1042/cs20030386 · Cited by 84
Self-citationPotassium channels are involved in testosterone-induced vasorelaxation of human umbilical artery
Cairrão, E., Álvarez, E., Santos-Silva, A. J., & Verde, I. (2007) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-007-0213-3 · Cited by 84
Haider, A., Gooren, L. J. G., Padungtod, P., & Saad, F. (2009) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/s-0029-1202774 · Cited by 83 · cited 1×
“Following 1 year of treatment with parenteral testosterone undecanoate, CRP decreased significantly in hypogonadal elderly men (Haider et al. 2009).”
BackgroundJones, R., Pugh, P., Hall, J., Channer, K., & Jones, T. (2003) · European Journal of Endocrinology · doi:10.1530/eje.0.1480111 · Cited by 82
Self-citationTestosterone modulates platelet aggregation and endothelial cell growth through nitric oxide pathway
Campelo, A. E., Cutini, P. H., & Massheimer, V. (2012) · Journal of Endocrinology · doi:10.1530/joe-11-0441 · Cited by 82
Effect of testosterone on ex vivo vascular reactivity in man
Malkin, C. J., Jones, R. D., Jones, T. H., & Channer, K. S. (2006) · Clinical Science · doi:10.1042/cs20050354 · Cited by 81
Self-citationMontaño, L. M., Calixto, E., Figueroa, A., Flores‐Soto, E., Carbajal, V., & Perusquía, M. (2008) · Endocrinology · doi:10.1210/en.2007-1288 · Cited by 81
Androgenic Maintenance of Inflow and Veno-Occlusion during Erection in the Rat
Mills, T. M., Lewis, R. W., & Stopper, V. S. (1998) · Biology of Reproduction · doi:10.1095/biolreprod59.6.1413 · Cited by 80
Testosterone and Erectile Dysfunction
Yassin, A. A., & Saad, F. (2008) · Journal of Andrology · doi:10.2164/jandrol.107.004630 · Cited by 78
Basic mechanisms of disease progression in the failing heart: The role of excessive adrenergic drive
Mann, D. L. (1998) · Progress in Cardiovascular Diseases · doi:10.1016/s0033-0620(98)80025-x · Cited by 77
Molecular requirements for L-type Ca2+ channel blockade by testosterone
Scragg, J. L., Dallas, M. L., & Peers, C. (2006) · Cell Calcium · doi:10.1016/j.ceca.2006.11.003 · Cited by 74
Nettleship, J., Pugh, P., Channer, K., Jones, T., & Jones, R. (2007) · Hormone and Metabolic Research · doi:10.1055/s-2007-976543 · Cited by 73
Self-citationThe Relationship Between Androgens and Arterial Stiffness in Older Men
Dockery, F., Bulpitt, C. J., Donaldson, M., Fernandez, S., & Rajkumar, C. (2003) · Journal of the American Geriatrics Society · doi:10.1046/j.1532-5415.2003.51515.x · Cited by 73
Prospective Study of Effect of Androgens on Serum Inflammatory Markers in Men
Ng, M. K. C., Liu, P. Y., Williams, A. J., Nakhla, S., Ly, L. P., Handelsman, D. J., & Celermajer, D. S. (2002) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000022167.80130.a6 · Cited by 73
Carson III, C. C., & Rosano, G. (2012) · The Journal of Sexual Medicine · doi:10.1111/j.1743-6109.2011.02337.x · Cited by 72
Androgen-Androgen Receptor System Protects against Angiotensin II-Induced Vascular Remodeling
Ikeda, Y., Aihara, K., Yoshida, S., Sato, T., Yagi, S., Iwase, T., Sumitomo, Y., Ise, T., Ishikawa, K., Azuma, H., et al. (2009) · Endocrinology · doi:10.1210/en.2008-1254 · Cited by 71
Testosterone Relaxes Isolated Human Radial Artery by Potassium Channel Opening Action
Seyrek, M., Yıldız, O., Ulusoy, H. B., & Yıldırım, V. (2007) · Journal of Pharmacological Sciences · doi:10.1254/jphs.fp0060883 · Cited by 71
Testosterone Propionate in the Treatment of Angina Pectoris
HAMM, L. (1942) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-2-5-325 · Cited by 70
Toot, J. D., Reho, J. J., Ramirez, R. J., Novak, J., & Ely, D. L. (2012) · Biology of Sex Differences · doi:10.1186/2042-6410-3-1 · Cited by 69
Rowell, K. O., Hall, J., Pugh, P. J., Jones, T. H., Channer, K. S., & Jones, R. D. (2009) · Journal of Endocrinological Investigation · doi:10.1007/bf03346526 · Cited by 65
Self-citationTestosterone Relaxes Human Internal Mammary Artery In Vitro
Yıldız, O., Seyrek, M., Gül, H., Ün, İ., Yıldırım, V., Özal, E., Uzun, M., & Bolu, E. (2005) · Journal of Cardiovascular Pharmacology · doi:10.1097/01.fjc.0000161400.06704.1e · Cited by 64
Relaxant Effects of 17-β-Estradiol in Cerebral Arteries through Ca2+ Entry Inhibition
Salom, J. B., Burguete, M. C., Pérez-Asensio, F. J., Torregrosa, G., & Alborch, E. (2001) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/00004647-200104000-00011 · Cited by 64
Perusquía, M., Navarrete, E., González, L., & Villalón, C. M. (2007) · Life Sciences · doi:10.1016/j.lfs.2007.07.024 · Cited by 64
WALKER, T. C. (1942) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-2-9-560 · Cited by 63
The Role of Andorgens in the Erectile Response: A 1999 Perspective.
MILLS, T. M., & Lewis, R. W. (1999) · PubMed · Cited by 63
Possible role of Ca2+ channels in the vasodilating effect of 5β-dihydrotestosterone in rat aorta
Perusquı́a, M., & Villalón, C. M. (1999) · European Journal of Pharmacology · doi:10.1016/s0014-2999(99)00161-2 · Cited by 62
Physiological testosterone replacement and arterial endothelial function in men
Sader, M. A., Griffiths, K. A., Skilton, M. R., Wishart, S. M., Handelsman, D. J., & Celermajer, D. S. (2003) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2003.01796.x · Cited by 62
Farhat, M. Y., Wolfe, R. A., Vargas, R., Foegh, M. L., & Ramwell, P. W. (1995) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-199503000-00023 · Cited by 55
Randomized, placebo-controlled trial
Abdukareem, A. A. (2004) · Annals of Saudi Medicine · doi:10.5144/0256-4947.2004.145 · Cited by 54
EDWARDS, E. A., Hamilton, J. B., & Duntley, S. Q. (1939) · New England Journal of Medicine · doi:10.1056/nejm193905252202103 · Cited by 53
Mechanisms involved in testosterone-induced vasodilatation in pig prostatic small arteries
Navarro‐Dorado, J., Orensanz, L. M., Recio, P., Bustamante, S., Benedito, S., Martínez, A. C., García‐Sacristán, A., Prieto, D., & Hernández, M. (2008) · Life Sciences · doi:10.1016/j.lfs.2008.08.009 · Cited by 52
Ponikowska, B., Jankowska, E. A., Maj, J., Węgrzynowska‐Teodorczyk, K., Biel, B., Reczuch, K. W., Borodulin-Nadzieja, L., Banasiak, W., & Ponikowski, P. P. (2009) · International Journal of Cardiology · doi:10.1016/j.ijcard.2009.03.072 · Cited by 51
English, K. M., Jones, R. D., Jones, H. T., Morice, A. H., & Channer, K. S. (2000) · Clinical Science · doi:10.1042/cs0990077 · Cited by 50
Norata, G. D., Cattaneo, P., Poletti, A., & Catapano, A. L. (2010) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2010.05.015 · Cited by 47
Cardiovascular effects of testosterone: implications of the “male menopause”?
Channer, K. S., & Jones, T. H. (2003) · Heart · doi:10.1136/heart.89.2.121 · Cited by 45
Self-citationYamada, K., Hayashi, T., Kuzuya, M., Naito, M., Asai, K., & Iguchi, A. (1996) · PubMed · Cited by 45
Kelly, D. M., Sellers, D. J., Woodroofe, M. N., Jones, T. H., & Channer, K. S. (2013) · Endocrine Research · doi:10.3109/07435800.2012.735307 · Cited by 40
Self-citationThe Treatment of Angina Pectoris with Testosterone Propionate
Lesser, M. A. (1942) · New England Journal of Medicine · doi:10.1056/nejm194201082260203 · Cited by 40
Estrogen attenuates vascular remodeling in Lp(a) transgenic mice
Nakagami, F., Nakagami, H., Osako, M. K., Iwabayashi, M., Taniyama, Y., Doi, T., Shimizu, H., Shimamura, M., Rakugi, H., & Morishita, R. (2010) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2010.01.016 · Cited by 39
Bettoun, D. J., Scafonas, A., Rutledge, S. J., Hodor, P. G., Chen, O., Gambone, C. J., Vogel, R., McElwee-Witmer, S., Bai, C., Freedman, L. P., et al. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.c500324200 · Cited by 39
The Inverse Relationship Between Thoracic Aortic Intima Media Thickness and Testosterone Level
Demirbağ, R., Yılmaz, R., Uluçay, A., & Ünlü, D. (2005) · Endocrine Research · doi:10.1080/07435800500449494 · Cited by 38
Characterization of the vasodilatory action of testosterone in the human pulmonary circulation
Smith, A. H., Bennett, R. T., Jones, T. H., Cowen, M. E., Channer, K. S., & Jones, R. D. (2008) · Vascular Health and Risk Management · doi:10.2147/vhrm.s3995 · Cited by 37
Self-citationTestosterone and Cholesterol Vasodilation of Rat Aorta Involves L-Type Calcium Channel Inhibition
Álvarez, E., Cairrão, E., Morgado, M., Morais, C., & Verde, I. (2010) · Advances in Pharmacological Sciences · doi:10.1155/2010/534184 · Cited by 37
The Vasodilatory Effect of Testosterone on Renal Afferent Arterioles
Lü, Y., Fu, Y., Ge, Y. C., Juncos, L. A., Reckelhoff, J. F., & Liu, R. (2012) · Gender Medicine · doi:10.1016/j.genm.2012.02.003 · Cited by 37
Cited by
Kelly, D. M., & Jones, T. H. (2015) · Obesity Reviews · doi:10.1111/obr.12282 · Cited by 487
Self-citationKlinefelter Syndrome: Integrating Genetics, Neuropsychology, and Endocrinology
Gravholt, C. H., Chang, S., Wallentin, M., Fedder, J., Moore, P., & Skakkebæk, A. (2018) · Endocrine Reviews · doi:10.1210/er.2017-00212 · Cited by 328
Testosterone and insulin resistance in the metabolic syndrome and T2DM in men
Rao, P. M., Kelly, D. M., & Jones, T. H. (2013) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2013.122 · Cited by 292
Self-citationSociety for Endocrinology guidelines for testosterone replacement therapy in male hypogonadism
Jayasena, C. N., Anderson, R. A., Llahana, S., Barth, J. H., MacKenzie, F., Wilkes, S., Smith, N., Sooriakumaran, P., Minhas, S., Wu, F. C. W., et al. (2022) · Clinical Endocrinology · doi:10.1111/cen.14633 · Cited by 147
Traish, A. M., Haider, A., Haider, K. S., Doros, G., & Saad, F. (2017) · Journal of Cardiovascular Pharmacology and Therapeutics · doi:10.1177/1074248417691136 · Cited by 130
Metadata
- Authors
- Kelly, D. M., & Jones, T. H.
- Venue
- Journal of Endocrinology
- Publisher
- Bioscientifica
- Published
- 2013-04-02
- Volume
- 217
- Issue
- 3
- Pages
- R47-R71
- ISSN
- 0022-0795 (ISSN-L)
- 1479-6805
- OpenAlex
- W2123593174
- Cited by
- 293
- References
- 221
- FWCI
- 18.87
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.